RICHTVXNEWS
FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
THE GUARDIAN · LONDON — The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels The US Food and Drug Administration (FDA) has issued a new warning on GLP-1 medications – which can facilitate weight loss – over a rare eye condition that could lead to sudden and permanent blindness . On…
- CODE
- RT-6CA42C
- PUBLISHER
- The Guardian
- TOPIC
- World
- PUBLISHED
- 10 November 2026 · 20:18 UTC
- FIRST SEEN
- 10 November 2026 · 20:45 UTC
- ORIGINAL
- https://www.theguardian.com/us-news/2026/nov/10/fda-glp-1-weight-loss-blindness-risk
- SHA-256
- af087baf0e90ffe4daa9bceda0b303cca33f9cb8f2e1f14187abb82dd3c2ffc8
The fingerprint is the SHA-256 of the original link, the headline and the publication time joined by “|”. Anyone can recompute it to confirm the headline and link were not changed here.
Headline and short excerpt from The Guardian, taken from its public news feed. The full story and its photos belong to The Guardian — read it at the original. RICHTVX NEWS is an independent aggregator and is not affiliated with The Guardian. Corrections: legal@richtvx.news.